These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19764836)

  • 21. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.
    Home PD; Barriocanal L; Lindholm A
    Eur J Clin Pharmacol; 1999 May; 55(3):199-203. PubMed ID: 10379635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
    Heinemann L; Weyer C; Rauhaus M; Heinrichs S; Heise T
    Diabetes Care; 1998 Nov; 21(11):1910-4. PubMed ID: 9802742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring adipose tissue blood flow in man: a comparison between the (133)xenon washout method and microdialysis.
    Karpe F; Fielding BA; Ilic V; Humphreys SM; Frayn KN
    Int J Obes Relat Metab Disord; 2002 Jan; 26(1):1-5. PubMed ID: 11791140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes.
    Herzig D; Dehais J; Prost JC; Nakas CT; Stettler C; Bally L; Hovorka R
    Diabetes Technol Ther; 2020 Sep; 22(9):691-696. PubMed ID: 31999478
    [No Abstract]   [Full Text] [Related]  

  • 27. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.
    Cengiz E; Weinzimer SA; Sherr JL; Tichy E; Martin M; Carria L; Steffen A; Tamborlane WV
    Pediatr Diabetes; 2013 May; 14(3):168-73. PubMed ID: 23107353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans.
    Ardilouze JL; Fielding BA; Currie JM; Frayn KN; Karpe F
    Circulation; 2004 Jan; 109(1):47-52. PubMed ID: 14662716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans.
    Asmar M; Simonsen L; Asmar A; Holst JJ; Dela F; Bülow J
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3155-62. PubMed ID: 27258938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump.
    Senstius J; Harboe E; Westermann H
    Diabetes Technol Ther; 2007 Feb; 9(1):75-9. PubMed ID: 17316101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
    Plum A; Agerso H; Andersen L
    Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
    Kildegaard J; Buckley ST; Nielsen RH; Povlsen GK; Seested T; Ribel U; Olsen HB; Ludvigsen S; Jeppesen CB; Refsgaard HHF; Bendtsen KM; Kristensen NR; Hostrup S; Sturis J
    Pharm Res; 2019 Feb; 36(3):49. PubMed ID: 30746556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.
    Thorisdottir RL; Parkner T; Chen JW; Ejskjaer N; Christiansen JS
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):216-21. PubMed ID: 19175369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart.
    Sohoel A; Plum A; Frokjaer S; Thygesen P
    Int J Pharm; 2007 Feb; 330(1-2):114-20. PubMed ID: 17070660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time contrast-enhanced ultrasound determination of microvascular blood volume in abdominal subcutaneous adipose tissue in man. Evidence for adipose tissue capillary recruitment.
    Tobin L; Simonsen L; Bülow J
    Clin Physiol Funct Imaging; 2010 Nov; 30(6):447-52. PubMed ID: 20731685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus.
    Petersen SB; Kildegaard J; Nielsen FS; Søndergaard E; Parkner T; Laursen T; Lauritzen T; Skyggebjerg O; Christiansen JS
    Diabetes Obes Metab; 2010 Apr; 12(4):334-40. PubMed ID: 20380654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.